188 related articles for article (PubMed ID: 34815287)
1. Protocol for a multicentre, parallel-group, open-label randomised controlled trial comparing ferric carboxymaltose with the standard of care in anaemic Malawian pregnant women: the REVAMP trial.
Mwangi MN; Mzembe G; Moya E; Braat S; Harding R; Robberstad B; Simpson J; Stones W; Rogerson S; Biselele K; Chinkhumba J; Larson L; Ataíde R; Phiri KS; Pasricha SR
BMJ Open; 2021 Nov; 11(11):e053288. PubMed ID: 34815287
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial.
Pasricha SR; Mwangi MN; Moya E; Ataide R; Mzembe G; Harding R; Zinenani T; Larson LM; Demir AY; Nkhono W; Chinkhumba J; Simpson JA; Clucas D; Stones W; Braat S; Phiri KS
Lancet; 2023 May; 401(10388):1595-1609. PubMed ID: 37088092
[TBL] [Abstract][Full Text] [Related]
4. Protocol and statistical analysis plan for a randomized controlled trial of the effect of intravenous iron on anemia in Malawian pregnant women in their third trimester (REVAMP - TT).
Harding R; Moya E; Ataíde R; Truwah Z; Mzembe G; Mhango G; Demir AV; Stones W; Randall L; Seal M; Johnson K; Bode S; Mwangi MN; Pasricha SR; Braat S; Phiri KS
Gates Open Res; 2023; 7():117. PubMed ID: 38343768
[TBL] [Abstract][Full Text] [Related]
5. A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy.
Khalafallah AA; Hyppa A; Chuang A; Hanna F; Wilson E; Kwok C; Yan C; Gray Z; Mathew R; Falloon P; Dennis A; Pavlov T; Allen JC
Semin Hematol; 2018 Oct; 55(4):223-234. PubMed ID: 30502851
[TBL] [Abstract][Full Text] [Related]
6. Intravenous versus oral iron for iron deficiency anaemia in pregnant Nigerian women (IVON): study protocol for a randomised hybrid effectiveness-implementation trial.
Afolabi BB; Babah OA; Akinajo OR; Adaramoye VO; Adeyemo TA; Balogun M; Banke-Thomas A; Quao RA; Olorunfemi G; Abioye AI; Galadanci HS; Sam-Agudu NA
Trials; 2022 Sep; 23(1):763. PubMed ID: 36076211
[TBL] [Abstract][Full Text] [Related]
7. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial.
Khalafallah AA; Yan C; Al-Badri R; Robinson E; Kirkby BE; Ingram E; Gray Z; Khelgi V; Robertson IK; Kirkby BP
Lancet Haematol; 2016 Sep; 3(9):e415-25. PubMed ID: 27570088
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial.
Vanobberghen F; Lweno O; Kuemmerle A; Mwebi KD; Asilia P; Issa A; Simon B; Mswata S; Schmidlin S; Glass TR; Abdulla S; Daubenberger C; Tanner M; Meyer-Monard S
Lancet Glob Health; 2021 Feb; 9(2):e189-e198. PubMed ID: 33245866
[TBL] [Abstract][Full Text] [Related]
9. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.
Lyseng-Williamson KA; Keating GM
Drugs; 2009; 69(6):739-56. PubMed ID: 19405553
[TBL] [Abstract][Full Text] [Related]
10. A Randomized controlled trial of the Effect of intraVenous iron on Anaemia in Malawian Pregnant women (REVAMP): Statistical analysis plan.
Harding R; Ataide R; Mwangi MN; Simpson JA; Mzembe G; Moya E; Truwah Z; Nkhwazi BC; Mwabinga M; Nkhono W; Phiri KS; Pasricha SR; Braat S
Gates Open Res; 2021; 5():174. PubMed ID: 35492865
[No Abstract] [Full Text] [Related]
11. Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial.
Jose A; Mahey R; Sharma JB; Bhatla N; Saxena R; Kalaivani M; Kriplani A
BMC Pregnancy Childbirth; 2019 Feb; 19(1):54. PubMed ID: 30717690
[TBL] [Abstract][Full Text] [Related]
12. Safety and effectiveness of intravenous iron sucrose versus standard oral iron therapy in pregnant women with moderate-to-severe anaemia in India: a multicentre, open-label, phase 3, randomised, controlled trial.
Neogi SB; Devasenapathy N; Singh R; Bhushan H; Shah D; Divakar H; Zodpey S; Malik S; Nanda S; Mittal P; Batra A; Chauhan MB; Yadav S; Dongre H; Saluja S; Malhotra V; Gupta A; Sangwan R; Radhika AG; Singh A; Bhaskaran S; Kotru M; Sikka M; Agarwal S; Francis P; Mwinga K; Baswal D
Lancet Glob Health; 2019 Dec; 7(12):e1706-e1716. PubMed ID: 31708151
[TBL] [Abstract][Full Text] [Related]
13. RAPIDIRON: Reducing Anaemia in Pregnancy in India-a 3-arm, randomized-controlled trial comparing the effectiveness of oral iron with single-dose intravenous iron in the treatment of iron deficiency anaemia in pregnant women and reducing low birth weight deliveries.
Derman RJ; Goudar SS; Thind S; Bhandari S; Aghai Z; Auerbach M; Boelig R; Charantimath US; Frasso R; Ganachari MS; Gaur KL; Georgieff MK; Jaeger F; Yogeshkumar S; Lalakia P; Leiby B; Majumdar M; Mehta A; Mehta S; Mehta S; Mennemeyer ST; Revankar AP; Sharma DK; Short V; Somannavar MS; Wallace D; Shah H; Singh M; Askari S; Bellad MB;
Trials; 2021 Sep; 22(1):649. PubMed ID: 34556166
[TBL] [Abstract][Full Text] [Related]
14. Intravenous ferric carboxymaltose rapidly increases haemoglobin and serum ferritin among pregnant females with moderate-to-severe anaemia: A single-arm, open-label trial.
Kant S; Haldar P; Malhotra S; Kaur R; Rath R; Jacob OM
Natl Med J India; 2020; 33(6):324-328. PubMed ID: 34341207
[TBL] [Abstract][Full Text] [Related]
15. Intravenous ferric carboxymaltose for anaemia in pregnancy.
Froessler B; Collingwood J; Hodyl NA; Dekker G
BMC Pregnancy Childbirth; 2014 Mar; 14():115. PubMed ID: 24667031
[TBL] [Abstract][Full Text] [Related]
16. Intravenous iron isomaltoside versus oral iron supplementation for treatment of iron deficiency in pregnancy: protocol for a randomised, comparative, open-label trial.
Markova V; Hansen R; Thomsen LL; Pinborg A; Moos T; Holm C
Trials; 2020 Aug; 21(1):742. PubMed ID: 32843079
[TBL] [Abstract][Full Text] [Related]
17. Role of Intravenous Ferric Carboxy-maltose in Pregnant Women with Iron Deficiency Anaemia.
Mishra V; Gandhi K; Roy P; Hokabaj S; Shah KN
J Nepal Health Res Counc; 2017 Sep; 15(2):96-99. PubMed ID: 29016575
[TBL] [Abstract][Full Text] [Related]
18. Single dose of intravenous ferric carboxymaltose infusion versus multiple fractionated doses of intravenous iron sucrose in the treatment of postoperative anaemia in colorectal cancer patients: study protocol for a randomised controlled trial.
Laso-Morales MJ; Vives R; Vallejo-Tarrat A; Caló N; Valle-Beltran A; Pontes C
Trials; 2019 Jan; 20(1):23. PubMed ID: 30616657
[TBL] [Abstract][Full Text] [Related]
19. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP).
Breymann C; Milman N; Mezzacasa A; Bernard R; Dudenhausen J;
J Perinat Med; 2017 May; 45(4):443-453. PubMed ID: 27278921
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty.
Bisbe E; Moltó L; Arroyo R; Muniesa JM; Tejero M
Br J Anaesth; 2014 Sep; 113(3):402-9. PubMed ID: 24780615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
